[go: up one dir, main page]

CA2564064A1 - Variations genetiques liees a des troubles psychiatriques - Google Patents

Variations genetiques liees a des troubles psychiatriques Download PDF

Info

Publication number
CA2564064A1
CA2564064A1 CA002564064A CA2564064A CA2564064A1 CA 2564064 A1 CA2564064 A1 CA 2564064A1 CA 002564064 A CA002564064 A CA 002564064A CA 2564064 A CA2564064 A CA 2564064A CA 2564064 A1 CA2564064 A1 CA 2564064A1
Authority
CA
Canada
Prior art keywords
mutation
melatonin
gene
point mutation
asmt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002564064A
Other languages
English (en)
Inventor
Thomas Bourgeron
Jonas Melke
Hany Goubran-Botros
Jean-Marie Launay
Marion Leboyer
Christopher Gillberg
Pauline Chaste
Richard Delorme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002523399A external-priority patent/CA2523399A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002564064A priority Critical patent/CA2564064A1/fr
Publication of CA2564064A1 publication Critical patent/CA2564064A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
CA002564064A 2005-10-14 2006-10-13 Variations genetiques liees a des troubles psychiatriques Abandoned CA2564064A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002564064A CA2564064A1 (fr) 2005-10-14 2006-10-13 Variations genetiques liees a des troubles psychiatriques

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002523399A CA2523399A1 (fr) 2005-10-14 2005-10-14 Variations genetiques liees a des troubles psychiatriques
CA2,523,399 2005-10-14
CA002564064A CA2564064A1 (fr) 2005-10-14 2006-10-13 Variations genetiques liees a des troubles psychiatriques

Publications (1)

Publication Number Publication Date
CA2564064A1 true CA2564064A1 (fr) 2007-04-14

Family

ID=37913504

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002564064A Abandoned CA2564064A1 (fr) 2005-10-14 2006-10-13 Variations genetiques liees a des troubles psychiatriques

Country Status (1)

Country Link
CA (1) CA2564064A1 (fr)

Similar Documents

Publication Publication Date Title
Udar et al. SOD1: a candidate gene for keratoconus
Houten et al. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome
Tolan Molecular basis of hereditary fructose intolerance: mutations and polymorphisms in the human aldolase B gene
Kwasnicka-Crawford et al. Characterization of a novel cation transporter ATPase gene (ATP13A4) interrupted by 3q25–q29 inversion in an individual with language delay
CA2595875A1 (fr) Methodes de diagnostique et de traitement de l'asthme, de la rhinite allergique et d'autres maladies respiratoires mettant en oeuvre une association d'haplotypes
Scimeca et al. Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis
Melander Genetic factors in hypertension–what is known and what does it mean?
CA2532203A1 (fr) Methodes de diagnostic et de traitement de l'asthme et d'autres maladies respiratoires reposant sur une association d'haplotypes
Caldovic et al. Mutations and polymorphisms in the human N‐acetylglutamate synthase (NAGS) gene
Sutomo et al. Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome
Wolf et al. Biotinidase deficiency: novel mutations and their biochemical and clinical correlates
EP1656458B1 (fr) Gene humain de susceptibilite a l'autisme et ses utilisations
AU2009246134B2 (en) Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type I diabetes
EP1948830B1 (fr) Variations genetiques associees a des troubles psychiatriques
Kiechle et al. Mitochondrial disorders: methods and specimen selection for diagnostic molecular pathology
CA2564064A1 (fr) Variations genetiques liees a des troubles psychiatriques
Shinozawa et al. Molecular characterization of 3 factor V mutations, R2174L, V1813M, and a 5-bp deletion, that cause factor V deficiency
Corte et al. Molecular analysis of 19 Spanish patients with mixed porphyrias
Lotfi et al. The beta cell glucokinase promoter variant is an unlikely risk factor for diabetes mellitus
AU2006225995B2 (en) Human autism susceptibility gene encoding a transmembrane protein and uses thereof
JP7301326B2 (ja) 新生児期～小児期発症の脳小血管病又はその保因者の検出方法
AU2006307640A1 (en) Genetic variants of human inositol polyphosphate-4-phosphatase, type I (INPP4A) useful for prediction and therapy of immunological disorders
JP2001252086A (ja) 方 法
US20020150931A1 (en) Bardet-biedl susceptibility gene and uses thereof
JP2002521061A (ja) ヒトのニューロキニン２受容体遺伝子における遺伝多型、並びに疾患の診断および処置におけるそれらの使用

Legal Events

Date Code Title Description
FZDE Dead